| 1 | [SID74373537] | Active | Potency | 11.5821 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Active | | Potency | 11.5821 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 2 | [SID74373537] | Active | Potency | 11.5821 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Active | | Potency | 11.5821 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 3 | [SID74373537] | Active | Potency | 11.5821 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Active | | Potency | 11.5821 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 4 | [SID74373537] | Active | Potency | 12.9953 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Active | | Potency | 12.9953 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 5 | [SID74373537] | Active | Potency | 12.9953 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Active | | Potency | 12.9953 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 6 | [SID74373537] | Active | Potency | 12.9953 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Active | | Potency | 12.9953 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 7 | [SID74373537] | Active | Potency | 15.8489 | qHTS of TDP-43 Inhibitors [AID652104, Type: confirmatory] | TAR DNA-binding protein 43 [gi:20140568] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS of TDP-43 Inhibitors | | AID | 652104 | | BioAssay type | confirmatory | | Target | TAR DNA-binding protein 43 [gi:20140568] | | PubMed | | | Data Table |  |
|
| 8 | [SID74373537] | Active | Potency | 18.3564 | A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. [AID624297, Type: confirmatory] | GMNN gene product [Homo sapiens] [gi:7705682] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Active | | Potency | 18.3564 [uM] | | BioAssay | A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. | | AID | 624297 | | BioAssay type | confirmatory | | Target | GMNN gene product [Homo sapiens] [gi:7705682] | | PubMed | | | Data Table |  |
|
| 9 | [SID74373537] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) [AID624466, Type: screening] | TAAR1 gene product [Homo sapiens] [gi:21264324] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) | | AID | 624466 | | BioAssay type | screening | | Target | TAAR1 gene product [Homo sapiens] [gi:21264324] | | PubMed | | | Data Table |  |
|
| 10 | [SID74373537] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) [AID624466, Type: screening] | TAAR1 gene product [Homo sapiens] [gi:21264324] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) | | AID | 624466 | | BioAssay type | screening | | Target | TAAR1 gene product [Homo sapiens] [gi:21264324] | | PubMed | | | Data Table |  |
|
| 11 | [SID74373537] | Active | | | uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay [AID624354, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Active | | BioAssay | uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay | | AID | 624354 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|
| 12 | [SID74373537] | Active | | | uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay [AID624354, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Active | | BioAssay | uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay | | AID | 624354 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|
| 13 | [SID74373537] | Active | | | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay [AID651596_6, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Active | | BioAssay | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay | | AID | 651596 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|
| 14 | [SID74373537] | Active | | | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay [AID651596_6, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Active | | BioAssay | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay | | AID | 651596 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|
| 15 | [SID74373537] | Active | | | Screen for inhibitors of the SWI/SNF chromatin remodeling complex (esBAF) in mouse embryonic stem cells with Luciferase reporter assay Measured in Cell-Based System Using Plate Reader - 2141-01_Inhibitor_SinglePoint_HTS_Activity [AID602393, Type: screening] | transcription activator BRG1 isoform 1 [Mus musculus] [gi:291463269] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Active | | BioAssay | Screen for inhibitors of the SWI/SNF chromatin remodeling complex (esBAF) in mouse embryonic stem cells with Luciferase reporter assay Measured in Cell-Based System Using Plate Reader - 2141-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 602393 | | BioAssay type | screening | | Target | transcription activator BRG1 isoform 1 [Mus musculus] [gi:291463269] | | PubMed | | | Data Table |  |
|
| 16 | [SID74373537] | Active | | | HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_SinglePoint_HTS_Activity [AID488896, Type: screening] | Scarb1 gene product [Mus musculus] [gi:14389423] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Active | | BioAssay | HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 488896 | | BioAssay type | screening | | Target | Scarb1 gene product [Mus musculus] [gi:14389423] | | PubMed | | | Data Table |  |
|
| 17 | [SID74373537] | Active | | | HTS to identify compounds that promote myeloid differentiation with MLPCN compound set [AID624256, Type: screening] | |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Active | | BioAssay | HTS to identify compounds that promote myeloid differentiation with MLPCN compound set | | AID | 624256 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 18 | [SID74373537] | Active | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Active | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 19 | [SID74373537] | Active | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Active | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 20 | [SID74373537] | Active | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Active | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 21 | [SID74373537] | Active | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Active | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 22 | [SID74373537] | Active | | | uHTS identification of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assay [AID651636, Type: screening] | GPR183 gene product [Homo sapiens] [gi:4826706] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Active | | BioAssay | uHTS identification of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assay | | AID | 651636 | | BioAssay type | screening | | Target | GPR183 gene product [Homo sapiens] [gi:4826706] | | PubMed | | | Data Table |  |
|
| 23 | [SID74373537] | Active | | | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504692, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Active | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504692 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 24 | [SID74373537] | Active | | | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504692, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Active | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504692 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 25 | [SID74373537] | Active | | | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504692, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Active | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504692 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 26 | [SID74373537] | Active | | | TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R [AID540295, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Active | | BioAssay | TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R | | AID | 540295 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 27 | [SID74373537] | Active | | | TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R [AID540295, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Active | | BioAssay | TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R | | AID | 540295 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 28 | [SID74373537] | Active | | | TRFRET-based cell-based high throughput confirmation assay for biased ligands (antagonists) of the melanocortin 4 receptor (MC4R) [AID602195, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Active | | BioAssay | TRFRET-based cell-based high throughput confirmation assay for biased ligands (antagonists) of the melanocortin 4 receptor (MC4R) | | AID | 602195 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 29 | [SID74373537] | Active | | | TRFRET-based cell-based high throughput confirmation assay for biased ligands (antagonists) of the melanocortin 4 receptor (MC4R) [AID602195, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Active | | BioAssay | TRFRET-based cell-based high throughput confirmation assay for biased ligands (antagonists) of the melanocortin 4 receptor (MC4R) | | AID | 602195 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 30 | [SID74373537] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 31 | [SID74373537] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 32 | [SID74373537] | Unspecified | | | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay [AID651596_7, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Unspecified | | BioAssay | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay | | AID | 651596 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|
| 33 | [SID74373537] | Unspecified | | | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay [AID651596_7, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Unspecified | | BioAssay | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay | | AID | 651596 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|
| 34 | [SID74373537] | Unspecified | | | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay [AID651596_8, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Unspecified | | BioAssay | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay | | AID | 651596 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|
| 35 | [SID74373537] | Unspecified | | | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay [AID651596_8, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Unspecified | | BioAssay | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay | | AID | 651596 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|
| 36 | [SID74373537] | Unspecified | | | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay [AID651596_9, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Unspecified | | BioAssay | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay | | AID | 651596 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|
| 37 | [SID74373537] | Unspecified | | | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay [AID651596_9, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Unspecified | | BioAssay | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay | | AID | 651596 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|
| 38 | [SID74373537] | Unspecified | | | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay [AID651596_10, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Unspecified | | BioAssay | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay | | AID | 651596 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|
| 39 | [SID74373537] | Unspecified | | | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay [AID651596_10, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Unspecified | | BioAssay | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay | | AID | 651596 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|
| 40 | [SID74373537] | Unspecified | | | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay [AID651596_2, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Unspecified | | BioAssay | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay | | AID | 651596 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|
| 41 | [SID74373537] | Unspecified | | | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay [AID651596_2, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Unspecified | | BioAssay | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay | | AID | 651596 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|
| 42 | [SID74373537] | Unspecified | | | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay [AID651596_3, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Unspecified | | BioAssay | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay | | AID | 651596 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|
| 43 | [SID74373537] | Unspecified | | | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay [AID651596_3, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Unspecified | | BioAssay | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay | | AID | 651596 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|
| 44 | [SID74373537] | Unspecified | | | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay [AID651596_4, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Unspecified | | BioAssay | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay | | AID | 651596 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|
| 45 | [SID74373537] | Unspecified | | | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay [AID651596_4, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Unspecified | | BioAssay | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay | | AID | 651596 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|
| 46 | [SID74373537] | Unspecified | | | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay [AID651596_5, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Unspecified | | BioAssay | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay | | AID | 651596 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|
| 47 | [SID74373537] | Unspecified | | | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay [AID651596_5, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Unspecified | | BioAssay | Single concentration confirmation of Caspase-8 TRAIL sensitizer hits in a luminesence panel assay | | AID | 651596 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|
| 48 | [SID74373537] | Inactive | Potency | 12.5893 | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen [AID588856, Type: confirmatory] | |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Inactive | | Potency | 12.5893 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen | | AID | 588856 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 49 | [SID74373537] | Inactive | Potency | 25.1189 | Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS [AID504937, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Inactive | | Potency | 25.1189 [uM] | | BioAssay | Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS | | AID | 504937 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 50 | [SID74373537] | Inactive | Potency | 25.1189 | Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS [AID504937, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 74373537 | | CID | 53313035 | | Outcome | Inactive | | Potency | 25.1189 [uM] | | BioAssay | Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS | | AID | 504937 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|